Summary
This 2021 International Consensus on Allergy and Rhinology provides an updated, evidence-based synthesis of recommendations for rhinosinusitis management, building on the original 2016 statement. The document covers over 180 topics including 22 high-grade medical management recommendations and 4 surgical recommendations, consolidated in this executive summary alongside a comprehensive management algorithm. The statement represents international expert consensus on the most effective interventions for common forms of rhinosinusitis.
UK applicability
As an international consensus statement, the recommendations are broadly applicable to UK rhinology and allergy practice. However, applicability may vary based on NHS service configuration, availability of specific surgical interventions, and differences in drug formulary approvals between the UK and other jurisdictions represented in the consensus.
Key measures
Evidence grade classifications (A/B) for medical and surgical treatment recommendations; number of topics covered (180+ total, 40+ new); structured recommendations from evidence-based review and recommendation (EBRR) sections
Outcomes reported
The study compiled evidence-based recommendations for medical and surgical treatment of rhinosinusitis across over 180 topics. Grade A/B recommendations for 22 medical management topics and 4 surgical management topics were synthesised into an executive summary with a comprehensive management algorithm.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.